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Cornelia de Lange Syndrome: NIPBL
haploinsufficiency downregulates canonical Wnt
pathway in zebrafish embryos and patients fibroblasts
A Pistocchi1,2, G Fazio3, A Cereda3, L Ferrari1, LR Bettini3, G Messina2, F Cotelli2, A Biondi3, A Selicorni3 and V Massa*,3,4
Cornelia de Lange Syndrome is a severe genetic disorder characterized by malformations affecting multiple systems, with a
common feature of severe mental retardation. Genetic variants within four genes (NIPBL (Nipped-B-like), SMC1A, SMC3, and
HDAC8) are believed to be responsible for the majority of cases; all these genes encode proteins that are part of the ‘cohesin
complex’. Cohesins exhibit two temporally separated major roles in cells: one controlling the cell cycle and the other involved
in regulating the gene expression. The present study focuses on the role of the zebrafish nipblb paralog during neural
development, examining its expression in the central nervous system, and analyzing the consequences of nipblb loss of
function. Neural development was impaired by the knockdown of nipblb in zebrafish. nipblb-loss-of-function embryos presented
with increased apoptosis in the developing neural tissues, downregulation of canonical Wnt pathway genes, and subsequent
decreased Cyclin D1 (Ccnd1) levels. Importantly, the same pattern of canonical WNT pathway and CCND1 downregulation was
observed in NIPBL-mutated patient-specific fibroblasts. Finally, chemical activation of the pathway in nipblb-loss-of-function
embryos rescued the adverse phenotype and restored the physiological levels of cell death.
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Cornelia de Lange Syndrome (CdLS) is a multiple malforma-
tion syndrome typically involving developmental delay,
specific facial features, behavioral abnormalities, and major
congenital malformations. Almost any organ can be affected,
but the most commonly observed defects are the ones that
affect the neurodevelopmental, gastrointestinal, and muscu-
loskeletal systems. There is a broad spectrum of clinical
involvement, with increasing recognition of a much milder
phenotype than previously appreciated. Clinically, a common
feature of CdLS is mental retardation that is often associated
with enlarged brain ventricles, thinning or atrophy of white
matter, brainstem hypoplasia, and cerebellar vermal hypo-
plasia or agenesis.1–3 During development, the central
nervous system (CNS) arises from the neural plate that folds
up on its anterior–posterior (AP) axis to form a tube divided in
three main units: the anlagen of the prosencephalon (fore-
brain), the mesencephalon (midbrain), and the rhombence-
phalon (hindbrain). Caudally, the tube will develop into the
spinal cord. These coordinated events are achieved through
a finely tuned balance between cell proliferation and pro-
grammed cell death. Within each region, a large diversity of
neuronal cell types is generated, each with distinct identities in
terms of their morphology, axonal trajectory, synaptic specifi-
cities, and neurotransmitters.4 This fundamental specification
is controlled by dorsoventral (DV) and AP gradients of
molecules. For example, components of the Wnt family are
known to induce anterior structures (such as forebrain),
whereas bone morphogenetic proteins are responsible for
neurogenesis in the dorsal neural tube.5
Genetically, CdLS is caused by both autosomal-dominant
and X-linked mutations. Approximately, 60% of the cases
are due to genetic defects in one of the four genes: NIPBL
(Nipped-B-like), SMC1A, SMC3, and the recently identified
HDAC8.1,6 NIPBL gene was the first to be found associated
with CdLS. SMC1A was subsequently identified as an
additional gene whose disruption produces the phenotypic
findings of the CdLS, whereas one CdLS case was reported
having a mutation in SMC3. HDAC8 was found to be mutated
in CdLS patients, consistent with its role in controlling
the acetylation status of SMC3. Most recently, mutations
in RAD21, a structural protein in the cohesin complex,
have been found in children with a spectrum of disabilities
overlapping with the CdLS syndrome, presenting with
milder cognitive impairments consistent with a so-called
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coesinopathy.3 All these genes encode proteins involved in
the ‘cohesin complex’.
The cohesin complex is evolutionarily conserved from fungi
to human cells, and its canonical role is the regulation of
chromatid separation during cell division.7 In particular, the
cohesin complex controls sister chromatid cohesion during
S phase. In the somatic cells of vertebrates, four core subunits
forming the complex have been identified: SMC1 (SMC1A or
SMC1B), SMC3, SCC1, and either SA1 or SA2. Associated
with the core complex, other proteins assist during cell
division, for example, NIPBL, which appears to facilitate the
uploading of the complex, or WAPL, which enables complex
dissociation.8
A non-canonical role has recently been observed, whereby
the cohesin complex also represents a key regulator of gene
expression. In Drosophila, NIPBL ortholog (i.e., Nipped-B)
has been shown to participate in the long-distance activation
of cut and Ultrabithorax gene expression.9 In zebrafish
(Danio rerio), cohesins regulate runx transcription factors
and hematopoiesis.10 Interestingly, it seems that functionally,
the cell cycle control and gene expression regulation are
temporally separated. For example, Drosophila mutants for
orthologs of cohesin complex genes show a defect in axon
retraction that physiologically occurs in post-mitotic neurons,
hence in cells that have exited the cell cycle.11 In zebrafish,
cohesins are expressed in both proliferating and non-proliferat-
ing cells,12 while mice that are heterozygous for Nipbl have
severe developmental defects and generally altered gene
expression in the absence of cell cycle or sister chromatid
impairment.13
A nipbl-deficiency model in zebrafish shows altered
expression of genes involved in endodermal differentiation
along with a spectrum of heart, gut, and visceral organ defects
that bear a striking similarity to those observed in CdLS
patients.14 In the present study, we have used two combined
approaches, zebrafish embryos and patient-derived cells, in
order to dissect molecular mechanisms underlying the
neurodevelopmental disorders. First, the effects of nipblb
loss of function in the developing CNS of zebrafish, in
particular at the hindbrain level, were characterized. The
results obtained from functional studies in zebrafish embryos
were then confirmed in fibroblasts of CdLS patients with
known mutation in NIPBL.
Results
Zebrafish nipblb is expressed in the CNS. In accordance
with the literature,12,14 nipblbwas ubiquitously expressed during
early somitogenesis in zebrafish embryos. The expression
progressively decreased in the trunk and appeared specifically
localized in the CNS at 24hpf (hours post fertilization)
(Figure 1a). As seen in this dorsal view, expression of nipblb
(Figure 1b) was detected in the diencephalon and mesence-
phalon, and highlighted the progression of hindbrain ventricle
opening. Histological longitudinal and transverse sections of
24hpf embryos clearly showed that nipblb is expressed
throughout the entire dorsal–ventral (DV) and AP axis of
the CNS (Figures 1c and d). Colocalization with krox20, a
marker of rhombomeres III and V,15 showed that nipblb
expression extended caudally as far as rhombomere V at this
developmental stage (Figure 1e).
Inhibition of Nipblb function in zebrafish embryos affect
CNS development. Embryos injected with nipblb-morpho-
lino (MO) began to exhibit defects at 24 hpf, including brain
defects (50% of nipblb-MO injected, total n¼ 200, Figures 2a
and b). In particular, nipblb-loss-of-function embryos were
microphthalmic and microcephalic. In addition, nipblb-
MO-injected embryos were presented with a short, curved
tail (40% of nipblb-MO injected, total n¼ 180, Figure 2b), a
phenotype previously described by Muto et al.14 following
nipblb loss of function. nipblb-MO efficiency and specificity
Figure 1 Expression analysis of nipblb. (a–d) WISH with nipblb-specific probe at 24 hpf. (a) Whole-mount embryo showing modulated nipblb expression along the AP axis.
c and d indicate the position of histological sections reported in c and d, respectively. (b) Dorsal view (anterior to the left) of the different regions of nipblb expression in the
CNS. (c) Transverse section of the neural tube showing that the nipblb transcript is ubiquitously expressed along the DV axis. (d) Longitudinal section showing nipblb
expression along the AP axis. (e) Comparison between nipblb (in blue) and krox20 (in red) expressions showing that nipblb extends posteriorly as far as rhombomere V at
24 hpf. di, diencephalon; m, midbrain; h, hindbrain; ot, otocystis. Scale bar, 100mm
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were verified by western blot experiments in which Nipbl
protein levels were reduced by 39% in nipblb-MO-injected
embryos at 24 hpf, compared with stage-matched control
embryos (Figures 2c and d).
nipblb downregulation affects cell survival but not cell
proliferation. When compared with controls, nipblb-MO-
injected embryos showed increased programmed cell death
in the CNS at 24hpf, whereas apoptosis was less
pronounced in CNS of control embryos (Figures 3a–d).
Interestingly, the TUNEL staining showed that the apoptotic
cells were most evident in the tissues expressing the nipblb
gene (compare Figure 1a and Figures 3b–d). Previous
studies in zebrafish described p53-dependent apoptosis
following cohesin smc3 knockdown, and p53 upregulation
in mutants for the cohesin subunit rad21.16,17 It is well known
that MO molecules could elicit undesirable off-target effects
such as activation of the p53 protein. Importantly, reversal of
p53-dependent cell death by p53 knockdown did not affect
cell death caused by specific gene loss of function.18 To
verify that apoptosis in nipblb-MO-injected embryos was due
to the specific loss of function of this gene and not a result of
p53 activation, we co-injected p53-MO with nipblb-MO. In
p53-MOþ nipblb-MO-injected embryos, the amount of apop-
totic cells were comparable to nipblb-loss-of-function embryos,
which verified that neural apoptosis was specifically caused by
knocking down nipblb (n¼ 42) (Supplementary Figure S1).
These results suggest that nipblb is required for cell survival
during neurulation in zebrafish embryos.
To determine whether nipblb loss of function also alters the
proliferation rate, embryos were stained with the proliferative
cell nuclear antigen antibody. As expected from previously
published studies on cohesin loss of function,10,19 we found
that entry into the S phase was not compromised, as the
number of proliferative cell nuclear antigen-positive cells in
nipblb-MO-injected embryos at 24 hpf was not significantly
increased in comparison with controls (Supplementary
Figure S2).
nipblb loss of function alters Wnt signaling pathway
expression. Owing to the expression of nipblb throughout
the CNS, we further investigated whether CNS AP formation
was altered in nipblb-loss-of-function embryos at 24 hpf.
The expression of AP identity markers, such as hoxb2a,20
pax2a,21 and krox20,15 was not altered in nipblb-MO-injected
embryos (Supplementary Figure S3), suggesting that the
CNS is patterned correctly. However, we found that wnt1
expression22 was severely altered in the hindbrain of nipblb-
MO-injected embryos at 24 hpf (80%, total analyzed embryos
n¼ 120; Figures 4a and b). It was possible to observe nipblb
knockdown phenotypes with different degrees of fusion of the
wnt1 signal in the hindbrain between rhombomere II and the
spinal cord: the most severe phenotype included a complete
fusion of the wnt1 hindbrain signals (20%, total n¼ 120), the
intermediate phenotype expressed multiple points of wnt1
fusion along the AP hindbrain axis (40%, total n¼ 120), and
the least severe phenotype presented either as a single point
of wnt1 fusion or as an incomplete opening of the ventricle
(20%, total n¼ 120, Figures 4a and b).
To investigate whether the observed defects were specific
for the mis-regulation of wnt1 expression following nipblb loss
of function or were caused by morphological defects in
hindbrain formation, we analyzed the expression of atoh1, a
marker of hindbrain dorsal progenitors and ventricle open-
ing.23 atoh1 expression was not altered in nipblb-MO-injected
embryos at 24 hpf (90%, total n¼ 50; Supplementary Figures
S4A and B), showing that anatomical patterning of the
developing brain is not affected by nipblb loss of function.
Figure 2 MO knockdown of nipblb. (a and b) Morphology of living embryos at 24 hpf. (a) Embryos injected with the ctrl-MO. (b) Embryos injected with the nipblb-MO
presenting brain defects and a curved tail. (c) Nipbl is reduced in MO-injected embryos by 39±0.04% compared with controls (expressed as mean of triplicate densitometric
analyses normalized against controls). (d) Western blot of protein extracted from minimum 30 embryos per experimental group showing reduced levels of Nipbl (316 KDa) in
two different batches of 24 hpf nipblb-MO-injected embryos compared with controls at the same developmental stage. Lower band is beta-actin (50 KDa)
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As defects in neural tube patterning might disrupt
neuronal differentiation, we examined the dopaminergic
population (thyrosin-hydroxilase-positive neurons) at 24 hpf
following nipblb loss of function. It is well known that
formation of mesencephalic dopaminergic neurons is
directed not only by diffusable signals from the notochord,
floor plate, and isthmic organizer such as Shh and Fgf, but
also by Wnt1 and other extrinsic factors.24 In nipblb-loss-of-
function embryos, we found that neurodifferentiation of this
population was not adversely affected (Supplementary
Figures S4C and D).
Importantly, comparable alterations in gene distribution
observed in wnt1 were also observed in axin2 expression
pattern,25 a key downstream component of the pathway
typically used as a readout of the cascade (Figures 4c
and d).
Expression profiling of the WNT/beta-catenin
pathway target genes in patients fibroblasts and
nipblb-MO-injected embryos. In zebrafish embryos, nipblb
loss of function resulted in alterations of the Wnt/beta-catenin
pathway, modeling the molecular defects underlying NIPBL-
mutated CdLS patients. Hence, we sought to analyze the
expression profile of this signaling pathway in fibroblasts of
patients, comparing it with that of cells obtained from age-,
ethnicity- and gender-matched healthy controls. Fibroblasts
are believed to represent a valid model for cohesin deficiency
in humans6 as in studies on gene expression, consistent
altered profiles were observed in primary cultures of
fibroblasts and lymphoblastoid cell lines.6
It was possible to exclude involvement of the non-canonical
pathway, as both DVL1 and DVL226 are comparable in
patients and control group (Supplementary Figures S5A and B).
Figure 3 Apoptosis is increased in the CNS of nipblb-loss-of-function embryos. (a and b) Apoptotic cells labeled with TUNEL were strongly increased in (b) nipblb-MO-
injected embryos at 24 hpf in comparison with control embryos (a) at the same developmental stage. (c and d) Transverse sections indicated prevalent cell death in the neural
tube of (d, arrow) nipblb-MO-injected embryos in comparison with controls (c). nt, neural tube. Scale bar, 100mm
Figure 4 wnt1 expression is specifically mis-regulated in the hindbrain of nipblb-MO-injected embryos. (a and b) wnt1 expression in controls and nipblb-MO-injected
embryos at 24 hpf. Altered wnt1 expression in the hindbrain of (b) nipblb-MO-injected embryos at 24 hpf in comparison with (a) controls at the same developmental stage.
Asterisks indicate multiple points of wnt1 fusion along the AP hindbrain axis of (b) nipblb-MO-injected embryos. (c and d) axin2 expression showing comparable defects of
patterning in nipblb-MO-injected embryos (d) in comparison with controls (c). Scale bar, 100 mm
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Analysis of the expression of direct targets of the canonical
pathway, such as Cyclins, by quantitative PCR (q-PCR)
showed a trend toward the reduction of Cyclin D1 (CCND1) in
NIPBL-mutated patients compared with healthy controls
(Figure 5a). As it is known that Cyclins can compensate
for the deficiency of other isoforms in mammals,27 we
also analyzed Cyclin D2 (CCND2) and found it to be
significantly upregulated (Po0.01) (Supplementary FigureS5C).
Consistently, a mean reduction of CCND1 levels of almost
50% was observed in patients samples when compared
with healthy controls (Figure 5c, Supplementary Figure 5D).
Ccnd1 was also found to be significantly downregulated in
nipblb-MO-injected embryos by q-PCR (Figure 5b), western
blot analysis with a decrease of Ccnd1 expression by 42%
(Figure 5d), and whole-mount in situ hybridization (WISH)
analyses (Figures 5e and f). The latter showed that the
Figure 5 The canonical Wnt pathway is downregulated in animal and human models of CdLS. (a and b) Human (CCND1) and zebrafish (ccnd1) real-time analysis in
(a) patients-specific fibroblasts and in (b) nipblb-MO-injected embryos showing a reduction trend of the transcripts in both models (asterisks in b represent Po0.01). (c and d; g
and h) Western blot analyses. Quantification of relative protein expression after normalization on beta-actin. The quantification was done on three (zebrafish) or two (human)
independent experiments and the data are expressed as fold change over relative controls with standard errors. (c and d). The reduction of CCND1 is confirmed at the protein
levels in CdLS patient-derived cells (c) and in nipblb-MO-injected embryos (d). (e and f) WISH analysis showing decreased expression levels of ccnd1 in nipblb-MO-injected
embryos (f) compared with control embryos (e) at the same developmental stage. (g and h) Levels of ABC were reduced in both CdLS models, that is, human (g) and zebrafish
(h), compared with specific controls. Asterisk in h represents Po0.05. (e and f) Dorsal view, anterior to the left
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expression of ccnd1 was altered in nipblb-MO-injected
embryos at 24 hpf in comparison with controls (40%, total
n¼ 30).
In addition, we found an average of 18% reduction of the
active form of beta-catenin (ABC)28 in patients compared with
controls after normalization (Figure 5g, Supplementary
Figure 5D). The same pattern was observed in nipblb-MO-
injected embryos with a statistically significant reduction of
ABC levels of 80% (Figure 5h).
Rescue of nipblb deficiency phenotype by chemical
induction of canonical Wnt pathway. As our data sugg-
ested that the adverse phenotype caused by knocking down
of nipblb in zebrafish embryos and in patients fibroblasts was
mediated by attenuation of the canonical Wnt pathway with a
subsequent decreased in Ccnd1 expression, we sought to
rescue the phenotype in nipblb-loss-of-function embryos by
chemical induction of the Wnt pathway by lithium chloride
(LiCl) treatment.29 The concentration used in three sets of
experiments failed to produce visible effects in control
embryos (minimum 30 per experiment), but was able to
strikingly reverse the defects induced by nipblb-MO injection
(minimum 30 per experiment). In particular, the cephalic
structures showed a restored morphology, and the wnt1
distribution pattern is similar to that of control embryos
(Figures 6a–c). Apoptosis levels determined by TUNEL
staining were reduced after LiCl treatment in nipblb-MO-
injected embryos to levels comparable to those of control
embryos (Figures 6d–f). Western blot analysis of nipblb-MO-
injected embryos treated with LiCl showed that the canonical
Wnt pathway was induced, as ABC levels were increased by
fourfold compared with controls and more than 10-fold
compared with nipblb-MO-injected embryos (Figures 6g–i).
Both differences were statistically significant. Notably,
Ccnd1 protein levels following LiCl treatment were induced
more than 3.7-fold compared with nipblb-MO-injected
embryos and 2.4-fold increase compared with controls.
(Figures 6h–j).
Figure 6 Molecular and morphological defects in CdLS zebrafish model can be rescued by LiCl treatment. (a–c) Dorsal view (anterior on the left) of flat-mounted embryos
showing altered wnt1 expression in nipblb-MO-injected embryos (b) with multiple points of fusion (asterisks) in comparison with controls (a), and restored wnt1 expression to
normal pattering in nipblb-MO-injected embryos treated with LiCl (c). (d and f) Lateral view of whole embryos stained with TUNEL assay showing that treatment with LiCl (f)
rescues the morphological cephalic defects and reduces level of abnormal apoptosis (e) restoring physiological levels comparable to control embryos (d). (g–j) Western blot
analyses showing that ABC (g–i) and Ccnd1 (h–j) protein levels are strongly increased in nipblb-MO-injected LiCl-treated embryos in comparison with nipblb-MO-injected
embryos. Western blot quantification was done on three (zebrafish) independent experiments, and the data are expressed as fold change in nipblb-MO-injected embryos and
nipblb-MO-injected LiCl-treated embryos over controls with standard errors. Asterisks in g represent *Po0.05 or **Po0.01
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Discussion
In this study, two different modeling strategies were used to
analyze abnormalities underlying CdLS, focusing on NIPBL,
which is themost commonlymutated gene in patients affected
by the disease.1,30 A developmental study in vivo using
zebrafish embryos was initially used to identify gene pathways
that might contribute to the phenotype, followed by a
validation study in which primary cultures of CdLS patients
fibroblasts were subsequently tested.
First, the expression of nipblb in the CNS of the zebrafish
embryos at 24hpf, the time when the neurulation process
is almost completed, was evaluated. This alleviates an existing
data gap in the literature, as the expression pattern of zebrafish
nipblb at different developmental stages had been previously
reported.12,14 The results showed a dynamic pattern of expres-
sion regulated spatio-temporally, with specific localization at
the level of the cephalic neural tissues. The other zebrafish
paralog nipbla had been reported with a similar expression
pattern and function in the developing visceral organs.14
Using MO technology, a model of haploinsufficiency in
zebrafish embryos was generated. This model mimics the
genetic haploinsufficiency of CdLS patients with mutation in
NIPBL. The nipblb-loss-of-function embryos showed severe
alterations of the head morphology, with various degrees of
microcephaly, microphthalmia, and incomplete development
of these cephalic structures.
This adverse phenotype correlatedwith increased apoptosis in
the areas where nipblb is normally expressed, suggesting that
the cohesins have an important functional role in cell survival of
specific tissues during vertebrate development. In our system,
the proliferation rate seemed unaffected. Interestingly, the
expression distribution of a number of markers of AP develop-
ment appeared comparable to control embryos.wnt1distribution,
on the other hand, was significantly impaired at the hindbrain
level, the prospect pons, medulla oblongata, and cerebellum, in
mammals. We ruled out that wnt1 expression alterations were
caused by abnormalities in anatomy of developing structures as
atoh1, which expression covers the entire dorsal and lateral
aspect of the cerebellar anlage,wasproperly distributed innipblb-
MO-injected embryos.31,32 Thewnt1 localization, however, failed
to be restricted to the lateral tissues in these embryos. This is
consistent with previous data indicating the presence of under-
lying anterio-posterior pattern in the absence ofWnt signals.33–35
The canonical Wnt pathway was found to be altered
in nipblb-MO-injected embryos and in patients fibroblasts.
In both cases, the ABC was downregulated. Ccnd1, a known
direct target of the pathway, was consequently downregulated
in both models. Noticeably, the abnormal cephalic phenotype
observed in nipblb-MO-injected embryos is strongly reminis-
cent of that observed after Ccnd1 knockdown.
Using LiCl as a well-known chemical activator of the
Wnt pathway,34,36 which negatively regulates GSK3b inhibition
of beta-catenin,37 it was possible to rescue the adverse
phenotype in nipblb-MO-injected embryos at all levels: anato-
mical cephalic structures appeared morphologically normal, the
programmed cell death levels were restored to physiological
levels seen in controls, and Ccnd1 protein levels were
increased. Interestingly, wnt1 pattern of expression appeared
rescued in zebrafish nipblb-MO-injected embryos by LiCl
treatment, suggesting that in our model, the primary adverse
event is at the Gsk3b-Beta-catenin complex level, and that
chemical compensation triggers a negative feedback on wnt1
expression control. In fact, it has been reported a negative
feedback through upregulation of Axin2 in a cancer model.38
Our CdLS zebrafish model suggests a role for the canonical
Wnt pathway perturbation in CNS abnormalities. In a murine
model of autosomic recessivemicrocephaly, the brain alterations
are caused by decrement in expression levels ofWnt1-regulated
genes, and overexpression of beta-catenin in neural cells could
rescue the defects.39 Several animal models with alterations in
Wnt-related gene expression show partially overlapping pheno-
type: the well-known masterblind (mbl) mutant, which develops
reduction of the telencephalon, optic vesicles ,and an abnormal
AP patterning, was found to be a spontaneous axin1mutant.34,35
Since then several mouse (for example, Hesx1, Six3, and
Tcf3),40–42 and zebrafish mutants43,44 have been described with
comparable phenotype at the AP patterning of the CNS during
embryonic development. In humans, HESX1 and SIX3 have
been found causative of hypopituitarism and septo-optic
dysplasia,45,46 a developmental disorder characterized by
severe defects in the brain and eye. In 1996, a case report
described a 5-year-old CdLS patient autopsy that revealed
hypoplasia of the optic systems, hypothalamic nuclei, corpus
callosum, and cerebellar vermis. Moreover, the septum pelluci-
dum, fornix, and anterior commissure were rudimentary. This
case showed features of septo-optic dysplasia combined with
commissural dysplasia and cerebellar vermian hypoplasia.47
It is known that decreased levels ofWnt1 signaling results in
the downregulation of Ccnd1 that leads to apoptosis in several
animal models.48–50 It is important to note that in mammals,
there is partial compensation by the upregulation of Ccnd2,27
as it was observed in our cell system. It is also known that
GSK3b overexpression induces increased apoptosis in vivo
perturbing proliferation and maturation, resulting in the loss of
immature neurons.51 The reduction of Wnt ligand levels or the
removal of the canonical pathway component beta-catenin
results in fewer neuroepithelial/radial glial stem cells and in
precocious neuronal differentiation in mouse embryos.52
Further, it has been shown that in murine models of
autism-like disorders, the most conspicuous phenotype is an
increase in programmed cell death in the developing
cerebellum.53,54 In CdLS patients, alterations in the develop-
ment of cerebellar structures at anatomical levels are known,
but more robust analyses with magnetic resonance imaging
could help unraveling the link between autism features,
seizures, and altered CNS development in these patients.
Increased apoptosis in our in vivo system led us to hypo-
thesize that, at least to some extent, the mental retardation
and autism-like behavior typically associated with CdLS
patients could have their roots in this abnormality. The
reported autopsy47 showed reduction of Purkinje cells number
in the cerebellum, and our data could implicate an imbalance
of cell death control during development as causative.
Several pieces of evidence suggest a possible regulation of
the Wnt pathway by cohesins in non- dividing cells in different
models. In skin fibroblasts expressing a mutated form of
HDAC8,WNT5A,WNT2,WISP2, and FZD8 were found to be
downregulated compared with wild-type cells.6 In Drosophila,
SMC3 appears important to control expression of Flamingo/
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Starry night (Fmi/Stan) the orthologs of vertebrate Celsr,
which is known to transduce the Wnt signaling cascade in
the non-canonical pathway to control cell polarity.55 It is
interesting to note that this regulation might be two-way, as in
colorectal cancer, the known upregulation of beta-catenin
appears to control expression of SMC3.56
In conclusion, this paper shows for the first time, to our
knowledge, a regulation of the Wnt-canonical pathway by
cohesins during development in zebrafish embryos and
in fibroblasts from CdLS patients. This suggests a potential
underlying mechanism for the developmental abnormalities
observed in the CNS of CdLS patients.
Materials and Methods
Animals. Breeding wild-type fish of the AB strain were maintained at 28 1C on
a 14-h light/10-h dark cycle. Embryos were collected by natural spawning, staged
according to Kimmel et al.,57 and raised at 28 1C in fish water (Instant Ocean,
United Pet Group, Blacksburg, VA, USA; 0.1% methylene blue) in Petri dishes,
according to established techniques, approved by the veterinarian (OVSAC) and
the animal use committee (IACUC) at the University of Oregon, in agreement with
local and national sanitary regulations. Embryonic ages are expressed in somites
(s), or hours post fertilization (hpf).
To activate Wnt/beta-catenin signaling, LiCl was added to fish water for 30min at
10–12 s stage at a concentration of 0.3 M at 28 1C. Treated embryos were then
washed three times with water and allowed to develop to 24 hpf.
In situ hybridization, histological analysis, and immunohisto-
chemistry. WISH experiments were carried out as described by Thisse et al.58
Immunohistochemistry analyses were performed according to the method described
by Panzer et al.59 For each experiment, a minimum of 30 controls and MO-injected
embryos were analyzed. To clone nipblb probe, a PCR was used (primers in
Supplementary Table S1); and krox20 probe was synthesized as described in Oxtoby
and Jowett;15 wnt1 probe was synthesized as described in Molven et al.;22 axin2
probe was synthesized as described in Shimizu et al.;25 atoh1 probe was synthesized
as described in Millimaki et al.,23 pax2a probe was synthesized as described in
Krauss et al.;21 hoxb2a probe was synthesized as described in Prince and
colleagues.20 For histological sections, stained embryos were re-fixed in 4%
paraformaldehyde, dehydrated and stored in methanol, and wax-embedded and
sectioned (5mm). For immunohistochemistry experiments, embryos were exposed to
specific primary antibodies (Supplementary Table S3), followed by appropriate
biotinylated secondary antibodies (Vector Laboratories, Burlingame, CA, USA).
Images of embryos and sections were acquired using a microscope equipped with
digital camera with LAS Leica Imaging software (Leica, Wetzlar, Germany). Images
were processed using the Adobe Photoshop software (Adobe System Incorporated,
San Jose`, CA, USA), and, when necessary, different focal planes of the same image
have been taken separately and later merged in a single image.
TUNEL staining. For TUNEL assay, a minimum of 24 embryos (per
experimental group) were fixed with 4% paraformaldehyde for 2 h at room
temperature. Embryos were washed with methanol at –20 1C and then twice with
PBC (0.001% Triton X-100, 0.1% sodium citrate in PBS) for 10min. Staining for
apoptotic cells was performed using the AP-In situ Cell Death Detection Kit (Roche
Diagnostics, Penzberg, Germany) carefully leaving labeling reagents to react for
the same length of time for all experiments. Embryos were incubated at 37 1C for
1 h, washed, stained, and mounted for microscopic imaging.
Injections. To repress nipblb mRNA translations, an ATG-targeting MO
(nipblb-MO) was synthesized (Gene Tools LLC, Philomath, OR, USA), nipblb-MO:
50-GTCCCCATTCATGCTGAAGAAGGGA-30, and used at the concentration of
1 pmol/embryo in 1 Danieau buffer (pH 7.6) as previously reported.60 As a
control, a standard control MO oligonucleotide (ctrl-MO) was injected. In all
experiments, nipblb-MO-injected embryos were compared with embryos injected
with the same amount of ctrl-MO at the same developmental stage. p53-MO was
designed (Gene Tools) and used as described in Robu et al.18
Cell cultures. Biopsies from four CdLS patients with known mutation in NIPBL
and three healthy controls (Supplementary Table S4) were used in this study.
Samples were obtained after signed informed consent. Healthy donors, two male
and one female Italian pediatric patients, were undergoing surgical procedures for
dermatological testing. Skin biopsies were collected from CdLS patients and
pediatric controls, and then finely shredded using a scalpel in sterile conditions.
Skin fragments were cultured in RPMI medium supplemented with 20% fetal
bovine serum. AfterB7–10 days, fibroblasts started to grow, and as soon as cell
confluence was reached, cells were collected, following standard trypsinization
procedure, suspended in Trizol reagent (Invitrogen, Life Technologies, Carlsbad,
CA, USA) or radio immunoprecipitation assay buffer, and stored at  80 1C.
For any experiments, same passaged (maximum P¼ 3) cells were compared.
Reverse transcription-PCR and real-time q-PCR assays. RNA
extraction was performed following the manufacturer’s protocol. Superscript II
enzyme (Life Technologies) was used for cDNA synthesis. Quantitative-reverse
transcription (RT)-PCRs on zebrafish embryos (minimum 30 per experimental
group) were carried out in a total volume of 25ml containing half volume of SYBR
Green (Life Technologies). For normalization purposes, ef1-alpha RNA level was
tested in parallel with the gene of interest. Primers are reported in Supplementary
Table S1. Melting curve derivatives were assessed for each run.
q-RT-PCR experiments on human samples were performed with Universal Probe
Master system (Roche Diagnostics). For this set of experiments, a Light Cycler 480II
(Roche Diagnostics) was used.
Primers and probes were selected according to the Software Probe Finder
(Roche Diagnostics) and are reported in Supplementary Table S2. ABL gene was
used as reference and healthy patients cells as standard control.
Western blot. Fish embryos (minimum 30 per experimental group) and human
fibroblasts were lysed in radio immunoprecipitation assay buffer and homogenized.
Samples were boiled for 10min at 95 1C with 20 reducing agent (Bio-Rad,
Hercules, CA, USA). Thirty micrograms of protein samples were size-fractionated by
pre-casted gel (4–15%, Bio-Rad) and transferred with following standard protocol. The
polyvinylidene fluoride membranes (Bio-Rad) were blocked with 10% nonfat dry milk in
TBST (TBS, pH 7.5, containing 0.1% Tween 20) for 1 h at room temperature and
subsequently incubated with the primary antibody. Primary antibodies were used at
appropriate working dilutions (Supplementary Table S3), in 5% milk/TBST over night at
4 1C. Horseradish peroxidase-conjugated secondary antibodies (Sigma-Aldrich,
St Louis, MO, USA) were used for 1 h at room temperature. The antigen signal
was detected with the immune-star chemiluminescence detection system (Bio-Rad) as
specified by the manufacturer. A StripAblot Stripping Buffer (Euroclone S.p.A., Milan,
Italy) was used to recover membranes. Densitometry analyses were performed using
Alliance instrument and Uviband software (Uvitec, Cambridge, UK). Beta-actin was
used as reference for protein concentrations and then data was expressed normalized
against control levels. For zebrafish embryos, experiments were run as three
independent experiments and for human fibroblasts in duplicates.
Statistical analysis. For q-RT-PCR experiments, data were statistically
analyzed applying a two-tailed t-test setting Pr0.05 as significant. Data were
analyzed using the comparative DDCt method20,60 both t-test and S.D. values
refer to samples triplicates. For western blot experiments, raw data were analyzed
applying a two-tailed paired t-test. Significance was set as Po0.05.
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